Quantum Biopharma Ltd. Class B Subordinate Voting Shares
6.96
USD
+0.05
+0.80%
Apr 25, 15:58 UTC -4
Closed
Pre-Market
6.75
-0.33
-4.59%
Quantum Biopharma Ltd. Class B Subordinate Voting Shares Profile
About
Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Quantum BioPharma, formerly known as FSD Pharma Inc., is based in Toronto, Ontario.
Info & Links
CEO
Zeeshan Saeed
Headquarters
55 University Avenue, Suite 1003 Toronto, A6 M5J 2H7, CANADA
Quantum Biopharma Ltd. Class B Subordinate Voting Shares Statistics
Valuation Measures
Market Capitalization2
2.02M
Enterprise Value
-3.21M
Enterprise Value/EBITDA(ttm)
0.20
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
0.58
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
-84.21%
Return on Invested Capital(ttm)
-129.45%
Return on Assets(ttm)
-62.63%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-15.65M
Net Income Available to Common(ttm)
-14.20M
Diluted EPS(ttm)
-15.41
Share Statistics
Beta (5Y Monthly)
0.61
52-Week Change
--
S&P 500 52-Week Change
8.00%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
2.30M
Dividend Yield
0.00%
Float4
1.75M
% Held by Insiders
8.53%
% Held by Institutions
1.24%
Balance Sheet
Total Cash(mrq)
8.06M
Total Cash Per Share(mrq)
3.50
Total Debt(mrq)
771.10K
Total Debt/Equity(mrq)
7.39%
Current Ratio(mrq)
1.80%
Quick Ratio(mrq)
3.76%
Book Value Per Share(mrq)
4.54
Cash Flow
Operating Cash Flow Per Share(ytd)
-6.05
Free Cash Flow(ytd)
-6.88M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.